Is Corporate Venture Capital a Prescription for Success in the Pharmaceutical Industry?

@inproceedings{Reaume2003IsCV,
  title={Is Corporate Venture Capital a Prescription for Success in the Pharmaceutical Industry?},
  author={Andrew G. Reaume},
  year={2003}
}
While venture capital investing may not appear to be aligned with the core activities of most corporations, it is a financial practice that has found its way into many technology-intensive businesses. Unlike traditional venture capital, corporate venture capital (CVC) primarily serves strategic purposes. Among the industries where CVC is prevalent, the pharmaceutical industry has many features that distinguish it from other technology-based businesses. For example, product development times are… 
What type of financing for innovative companies ? Analysis of investment decisions by venture capitalists-Evidence from a theoretical model of venture capital financing in biotechnology companies *
Nowadays, many biotechnology companies are the source of scientific and technological breakthroughs and this is especially true in the pharmaceutical industry. However, developing such innovations is
Exploring the landscape of corporate venture capital: a systematic review of the entrepreneurial and finance literature
The influence of corporate venture capital (CVC) investments within the venture capital industry, that is, equity stakes in high technology ventures, has stimulated the academic literature on this
The use of corporate venture capital as a strategic tool: Literature review and key characteristics of CVC investments
The exploration and exploitation of innovative opportunities are the essence of corporate entrepreneurial activities. In the scientific literature, the responsibility and ability of firms to pursue
Strategic effects of corporate venture capital investments
This paper analyzes the strategic effects of corporate venture capital investments. Specifically, by studying the deals of 163 corporations over a four-year period, it documents the effects of
Coopetition in corporate venture capital: the relationship between network attributes, corporate innovativeness, and financial performance
TLDR
By strategically managing its position in a CVC network, coopetitors increase their own innovativeness that lead to superior financial outcomes that are positively related to subsequent financial performance.
Formative Experience and Organizational Performance: Evidence from Corporate Venture Capital
What is the effect of a formative experience on organizational performance? We use data from 207 corporations who made corporate venture capital investments in the period 1998-2001 to explore the
From East to West: a Japanese Pharma perspective on establishing a global research capability.
TLDR
The strategies, opportunities and challenges of building a global research network from the perspective of a Japanese Pharmaceutical company are outlined.
RISKY INFORMATION EXCHANGE: HOW NETWORK POSITION CAN CAUSE DIFFICULTIES FOR CORPORATE INNOVATION
To enhance innovation effectiveness, many incumbent corporations make equity investments in young technological startups. Four out of five corporate investors syndicate at least some of their inves

References

SHOWING 1-4 OF 4 REFERENCES
Making sense of corporate venture capital.
TLDR
A framework that will help a company decide whether it should invest in a particular start-up by first understanding what kind of benefit might be realized from the investment, and explains why certain types of corporate VC investments proliferate only when financial returns are high, why other types persist in good times and in bad, and why still others make little sense in any phase of the business cycle.
Venture Capital and Private Equity: A Casebook
Introduction. 1. Private Equity Today and Tomorrow. 2. Tad O'Malley: December 2004. Module 1: Venture Capital and Private Equity. 3. Yale University Investment Office: August 2006. 4. Pawson
Ernst & Young Corporate Venture Capital Report
  • 2002
Corporate Venture Capital's Complex Agenda